Skip to main content
Novartis Top Menu
  • Novartis.com
Novartis Foundation LOGO
    • About Us
      • Board of Trustees
        • Joerg Reinhardt, Ph.D.
        • Ann Aerts, M.D.
        • Dr. Jo Ivey Boufford
        • Lutz Hegemann, M.D., Ph.D.
        • John Kahan
        • Prof. Peter Piot, M.D.
      • Our Team
        • Johannes Boch
        • Cristina Haffner
        • Lucy Setian
        • Sarah Des Rosiers
        • Xavier Sutter
      • Our partners
      About Us
    • Transforming population health
      • Cardiovascular population health initiative
      • AI4BetterHearts
      • AI in health policy
        • Broadband Commission Working Group on Digital and AI in Health
        • HealthTech Dialogue Hub
        • AI4HealthyCities
      • HealthTech Innovation
        • Brazil COVID-19 response
        • AI4Leprosy
        • HealthTech Hub Africa
      Transforming Population Health
    • Urban Population Health Toolkit
      • Quality of care
      • Ensure access
      • Policy reform
      • Leverage data and digital
      • Intersectoral collaboration
      • Ensure local ownership
      Urban Population Health Toolkit
    • Past programs
      • Better Hearts Better Cities
        • Community-based Hypertension Improvement Project (ComHIP)
        • Communities for Healthy Hearts
        • KaziBantu (Healthy Schools for Healthy Communities)
      • Leprosy and malaria elimination
        • The Leprosy Alert and Response Network System (LEARNS)
        • Leprosy Post-Exposure Prophylaxis (LPEP) program
        • Malaria Targeted Parasite Elimination Strategy
      • Digital Health
        • Ghana Telemedicine
        • Telemedicine Toolkit
        • Integrated e-Diagnostic Approach
      Past Programs
    • Media Center
      • News Archive
      • Media Library
      • Stories
      Media Center
    Homepage
  1. Home
  2. Media Center
  3. Media Library

Evaluating the Feasibility of Reactive Targeted Parasite Elimination vs. Reactive Case Detection, With and Without Reactive Vector Control, As a Community Level Intervention in Response to Confirmed, Passively Identified Index Cases in Zambezi Region

Back to Previous Page
Cover Malaria - feasibility of reactive targeted parasite elimination vs. reactive case detection
Description

As a result of successful malaria control efforts, Namibia, like many countries in southern Africa, is aiming for elimination by 2020.

Evaluating the Feasibility of Reactive Targeted Parasite Elimination vs. Reactive Case Detection, With and Without Reactive Vector Control, As a Community Level Intervention in Response to Confirmed, Passively Identified Index Cases in Zambezi Region (PDF 1009.34 KB)

Related Items

  • Document
    lock
    Malaria, Publication
    Targeted Parasite Elimination for Malaria Elimination in Namibia
  • Document
    lock
    Malaria, Publication
    Evaluating the Effectiveness and Feasibility of Reactive Focal Mass Drug Administration vs. Reactive Case Detection, With and Without Reactive Vector Control, As a Community Level Intervention in Response to Confirmed, Passively Identified Malaria Cases
  • Document
    lock
    Malaria, Publication
    Child Mortality Patterns in Rural Tanzania: An Observational Study on the Impact of Malaria Control Interventions

Novartis Foundation

Navigate Novartis Foundation
  • About Us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs
About the Novartis Foundation
  • Board of Trustees
  • Our Partners
  • Our Team
Media Center
  • News Archive
  • Media Library
  • Our Stories
Footer Bottom
© 2022 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for a global audience